Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

USP54 Inhibitors

The class of compounds known as USP54 inhibitors represents a group of chemical entities that are designed to selectively target and inhibit the enzymatic activity of Ubiquitin Specific Peptidase 54 (USP54). USP54 is a deubiquitinating enzyme that plays a crucial role in modulating the ubiquitin-proteasome system, a fundamental cellular process responsible for the controlled degradation of proteins. The ubiquitin-proteasome system ensures the removal of damaged, misfolded, or regulatory proteins, thereby maintaining cellular homeostasis. USP54, as a deubiquitinase, counteracts ubiquitination by removing ubiquitin moieties from protein substrates, effectively hindering their degradation.

USP54 inhibitors are meticulously designed molecules that interfere with the catalytic activity of USP54. These inhibitors often feature intricate chemical structures, carefully engineered to fit into the active site of the enzyme. By binding to the active site, these inhibitors obstruct the enzyme's ability to recognize and cleave ubiquitin from target proteins, consequently impeding the deubiquitination process. This disruption can have downstream effects on protein turnover and cellular signaling pathways, leading to alterations in cellular processes that rely on proper protein degradation and turnover. The chemical diversity within the USP54 inhibitor class is vast, encompassing various structural motifs and functional groups. Researchers in this field employ diverse synthetic strategies to create a repertoire of compounds with the ability to inhibit USP54's enzymatic activity. These inhibitors are characterized by their specific interactions with the enzyme's active site residues, which contribute to their binding affinity and selectivity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

UCH-L3 Inhibitor

30675-13-9sc-204370
10 mg
$153.00
1
(0)

Another small molecule inhibitor of USP54 that showed potential in increasing the degradation of cellular proteins, which could have implications in various diseases.